Guru Ownership Trend
Guru Analysis for Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (XENE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $55.96 M.
Top institutional holders include Paul Tudor Jones and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $39.55 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Xenon Pharmaceuticals Inc. (XENE)
Major holders include Paul Tudor Jones ($28.82 M), Renaissance Technologies (RenTech) ($17.47 M), Stanley Druckenmiller ($13.88 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.04 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $39.55 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited XENE. The total reported sell value was $6.27 M.
Yes, 3 managers opened new positions in XENE, and 1 increased their existing holdings. The total reported buy value was $45.82 M.